ZhaoXGaoCChenHChenXLiuTGuD.C-reactive protein: an important inflammatory marker of coronary atherosclerotic disease. Angiology. 2026;77:145-160.
2.
ParaskevasKIMikhailidisDP.C-reactive protein (CRP): more than just an innocent bystander?Curr Med Res Opin. 2008;24: 75-8.
3.
CasasJPShahTCooperJ, et al. Insight into the nature of the CRP-coronary event association using Mendelian randomization. Int J Epidemiol. 2006;35:922-31.
4.
PepysMB.CRP or not CRP? That is the question. Arterioscler Thromb Vasc Biol. 2005;25:1091-4.
5.
GiannakopoulouSPAntonopoulosAPanagiotakosD.Serum inflammatory markers used in cardiovascular disease risk prediction models: a systematic review. Angiology. 2026;77:137-144.
6.
RidkerPMEverettBMThurenT, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377:1119-31.
7.
WeberCvon HundelshausenP.CANTOS trial validates the inflammatory pathogenesis of atherosclerosis: setting the stage for a new chapter in therapeutic targeting. Circ Res. 2017;121:1119-21.
8.
ArnettDKBlumenthalRSAlbertMA, et al. 2019ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e596-646.
9.
VisserenFLJMachFSmuldersYM, et al. 2021ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42:3227-337.
10.
VrintsCAndreottiFKoskinasKC, et al. 2024ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45:3415-537.
